Eprontia Solution
Product Images NDC 52652-9001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eprontia (NDC 52652-9001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bottle Label)

Principal Display Panel (Bottle Label)
Eprontia (topiramate) oral solution 25 mg/mL label showing a 473 mL bottle size. It is for oral use only, ready to use, and dispensed with an oral dosing syringe and medication guide. Manufactured by Azurity Pharmaceuticals, Inc., Wilmington, MA.*
FDA Label Image

Structural Formula (Image 02)

Structural Formula (Image 02)
Chemical structure of topiramate, showing its molecular arrangement with functional groups including sulfonamide, bicyclic sugar-like ring, and multiple methyl groups.*
FDA Label Image

Figure 1 (Image 03)

Figure 1 (Image 03)
A Kaplan-Meier cumulative incidence plot showing the time to first seizure in days for patients treated with Topiramate at doses of 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative rates for time to first seizure. Two lines represent the two dosing groups, with a noted p-value of 0.0002 indicating statistical comparison.*
FDA Label Image

Figure 2 (Image 04)

Figure 2 (Image 04)
A bar chart illustrating the change from baseline to the double-blind phase in average monthly migraine period rate (± standard error) for placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart compares results from Study 11 and Study 12, showing greater reductions in migraine rates with increasing Topiramate doses, and statistical significance is indicated by asterisks for p-values less than 0.010 and 0.001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.